Biotech Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH September 9, 2026
Biotech Sky Labs Showcases ‘CART BP pro’ for Potential Use in Drug Clinical Trials on Global Stage August 22, 2026
Biotech Startup Island TAIWAN-Led Delegation Secures More Than 100 Business Meetings at BIO 2026, Expanding Global Opportunities for Taiwanese Biotech Startups August 15, 2026
Biotech Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilities and Drive Operational Excellence August 5, 2026
Biotech Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy August 1, 2026
Biotech WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year July 31, 2026
Biotech RYBODYN AWARDED $1.3M DOW GRANT TO ADVANCE NOVEL ANTIBODY THERAPIES FOR LUNG CANCER July 30, 2026